Can Albumin 5% 1000 mL Be Given for Septic Shock?
Yes, albumin 5% can be given to patients with septic shock, but only as an adjunct to crystalloids when substantial amounts of crystalloids have already been administered—not as first-line therapy. Crystalloids remain the primary resuscitation fluid, and albumin should be reserved for rescue situations after large crystalloid volumes have been given 1.
Guideline-Based Approach
First-Line Resuscitation
- Start with crystalloids (either balanced crystalloids or normal saline) as the initial fluid of choice for resuscitation 1
- Administer at least 30 mL/kg of crystalloids as the initial fluid challenge
- Continue crystalloid administration as long as hemodynamic factors improve
When to Consider Albumin
Add albumin 5% only when:
- The patient requires "substantial amounts" of crystalloids (typically interpreted as ≥30 mL/kg or ongoing large volume requirements)
- Hemodynamic instability persists despite adequate crystalloid resuscitation
- This is a weak recommendation with low-to-moderate quality evidence 1
Volume Considerations for 1000 mL of 5% Albumin
The 1000 mL volume you're asking about is reasonable and commonly used:
- FDA labeling supports albumin 5% for hypovolemic shock and sepsis-related hypoproteinemia 2
- The 2024 International Collaboration guideline notes that albumin has not shown mortality benefit but is not harmful when used appropriately 3
- Monitor closely for circulatory overload, as albumin 5% is iso-oncotic and expands plasma volume approximately 1:1 with the infused volume
Critical Evidence Nuances
Mortality Data
The most recent high-quality evidence shows:
- No mortality benefit from albumin in septic shock across multiple systematic reviews 3, 4, 5
- A 2026 German RCT (INCEPT-Albumin) found no difference in 90-day mortality (43.3% vs 45.9%, p=0.71) 6
- Trial sequential analysis suggests we have reached futility—meaning further studies are unlikely to show benefit 5
Concentration Matters
- 5% albumin is preferred over 25% albumin for septic shock resuscitation
- Recent 2025 data suggests 25% albumin may increase risk of RRT or mortality (OR 1.43) in patients with renal impairment, while 5% showed no significant difference (OR 1.07) 7
- The 2024 guideline emphasizes lack of proven benefit and higher cost compared to crystalloids 3
Important Caveats and Pitfalls
Do NOT Use Albumin If:
- Pediatric patients with febrile illness: A large RCT (FEAST trial, N=3,141) showed increased mortality with albumin boluses in children with severe febrile illness (RR 1.45) 3
- As first-line fluid: This violates all major guidelines
- For chronic hypoalbuminemia alone: In chronic nephrosis or cirrhosis without shock, albumin is rapidly excreted and provides no benefit 2
Monitor For:
- Circulatory overload: Administer no faster than 2 mL/min in hypoproteinemic patients to avoid pulmonary edema 2
- Renal function: In patients with baseline kidney impairment (eGFR <45), early albumin may increase risk of RRT requirement 7
- Fluid balance: The 2024 CLASSIC trial showed substantial practice variation, with albumin use ranging from 36-53% depending on fluid strategy 8
Practical Algorithm
- Initial resuscitation: Give 30 mL/kg crystalloids rapidly
- Reassess hemodynamics: If shock persists after initial crystalloid bolus
- Continue crystalloids: Give additional crystalloid boluses with hemodynamic monitoring
- Consider albumin 5%: Only after ≥30-60 mL/kg crystalloids given and shock persists
- Dose: 1000 mL (50 g) of 5% albumin is a reasonable rescue dose
- Rate: Can give faster in shock (unlike hypoproteinemia without shock)
- Reassess frequently: Continue only if hemodynamic improvement occurs
The bottom line: Albumin 5% 1000 mL can be given, but crystalloids must come first, and the evidence does not support expecting improved survival—only potential hemodynamic support as a rescue measure 3, 1.